PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Lee DR et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells. 2009 Toxicology pmid:19167456
Chen HH et al. Effects of trichloroethylene and perchloroethylene on muscle contractile responses and epithelial prostaglandin release and acetylcholinesterase activity in swine trachea. 2005 Toxicol. Sci. pmid:15496499
Maddox JF et al. 15-deoxy prostaglandin J2 enhances allyl alcohol-induced toxicity in rat hepatocytes. 2004 Toxicol. Sci. pmid:14657518
Higuchi S et al. IL-4 mediates dicloxacillin-induced liver injury in mice. 2011 Toxicol. Lett. pmid:21094227
Suk FM et al. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells. 2009 Toxicol. Lett. pmid:19429239
Kang DS et al. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism. 2006 Toxicol. Appl. Pharmacol. pmid:16890972
Lim HJ et al. 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells. 2007 Toxicol. Appl. Pharmacol. pmid:17631927
Ibabe A et al. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes. 2005 Toxicol In Vitro pmid:15964169
Kumagai M et al. 15-Deoxy-delta(12,14)-prostaglandin J2 inhibits the IL-1beta-induced expression of granulocyte-macrophage colony-stimulating factor in BEAS-2B bronchial epithelial cells. 2004 Tohoku J. Exp. Med. pmid:14998300
Nakazawa I et al. Some features in prostaglandin synthesis of the cancer cells which metastasized into liver from intestinal cancer lesions. 1993 Tohoku J. Exp. Med. pmid:8266326
Takeda K et al. Neuroendocrine functions of melanocytes: beyond the skin-deep melanin maker. 2007 Tohoku J. Exp. Med. pmid:17347546
Orchard MA et al. Thromboxane synthase inhibition causes re-direction of prostaglandin endoperoxides to prostaglandin D2 during collagen stimulated aggregation of human platelet rich plasma. 1985 Thromb. Res. pmid:3936223
Chou TC and Li CY Inhibitory mechanisms of dantrolene on platelet aggregation. 1999 Thromb. Res. pmid:10593433
Lin CH et al. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. 1992 Thromb. Res. pmid:1412184
Ide T et al. Activation of nuclear receptors by prostaglandins. 2003 Thromb. Res. pmid:14592554
Chen WY et al. The effect of 3-[2-(cyclopropylamino)ethoxy]xanthone on platelet thromboxane formation. 1994 Thromb. Res. pmid:8073410
Fortini A et al. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets. 1985 Thromb. Res. pmid:3001968
Kanehara H et al. Thrombomodulin expression by THP-1 but not by vascular endothelial cells is upregulated by pioglitazone. 2002 Thromb. Res. pmid:12617986
Xie S et al. 15 deoxy delta12,14 PGJ2 induces procoagulant activity in cultured human endothelial cells. 2002 Thromb. Haemost. pmid:11916086
Inoue T et al. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. 2001 Thromb. Haemost. pmid:11204569
Hardy E et al. Magnesium modifies the responses of platelets to inhibitory agents which act via cAMP. 1995 Thromb. Haemost. pmid:8560425
Eligini S et al. 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. 2002 Thromb. Haemost. pmid:12353085
Bertelé V et al. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor. 1984 Thromb. Haemost. pmid:6326343
Artwohl M et al. Thiazolidinediones inhibit apoptosis and heat shock protein 60 expression in human vascular endothelial cells. 2005 Thromb. Haemost. pmid:15886792
Blockmans D et al. Heparin-induced thrombocytopenia platelet aggregation studies in the presence of heparin fractions or semi-synthetic analogues of various molecular weights and anticoagulant activities. 1986 Thromb. Haemost. pmid:3518134
Black PN et al. Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects. 1989 Thorax pmid:2548300
Sampson SE et al. Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4. 1997 Thorax pmid:9227716
Brugha RE et al. Carbon in airway macrophages from children with asthma. 2014 Thorax pmid:24567296
Dahlén SE and Kumlin M Monitoring mast cell activation by prostaglandin D2 in vivo. 2004 Thorax pmid:15170020
Bochenek G et al. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. 2004 Thorax pmid:15170023
Montuschi P et al. Exhaled leukotrienes and prostaglandins in COPD. 2003 Thorax pmid:12832671
O'Sullivan S et al. Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine. 1998 Thorax pmid:10195076
Yokoyama Y et al. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells. 2010 Ther Apher Dial pmid:20438519
Shiraki T et al. [Activation mechanism of PPARgamma by its endogenous ligands]. 2005 Tanpakushitsu Kakusan Koso pmid:16277244
Fukushima M [Prostaglandins and cell proliferation]. 1991 Tanpakushitsu Kakusan Koso pmid:2024021
Tanaka H et al. [Synthesis of chemical probes based on combinatorial chemistry and lab automation]. 2007 Tanpakushitsu Kakusan Koso pmid:18051395
Urade Y [Structure and function of prostaglandin D synthase]. 2008 Tanpakushitsu Kakusan Koso pmid:18326294
Satoh T and Watanabe Y [Cyclopentenone prostaglandin derivatives as neuroprotective compounds]. 2002 Tanpakushitsu Kakusan Koso pmid:12486935
Stringfellow DA Prostaglandins and metastasis. 1983 Symp Fundam Cancer Res pmid:6206537
Farrow B et al. Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator. 2003 Surgery pmid:12947319
Yoshida T et al. Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer. 1998 Surg. Today pmid:9697269
Saito K et al. Blood components contribute to rise in gerbil brain levels of leukotriene-like immunoreactivity after ischemia and reperfusion. 1988 Stroke pmid:3274043
Ban M et al. A flavonoid inhibitor of 5-lipoxygenase inhibits leukotriene production following ischemia in gerbil brain. 1989 Stroke pmid:2919414
Gaetani P et al. Effect of high-dose methylprednisolone and U74006F on eicosanoid synthesis after subarachnoid hemorrhage in rats. 1991 Stroke pmid:1900645
Kempski O et al. Postischemic production of eicosanoids in gerbil brain. 1987 Jan-Feb Stroke pmid:3468670
Blanco M et al. Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. 2005 Stroke pmid:15879329
Xu X et al. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation. 2013 Steroids pmid:23707573
Le Mée S et al. 7beta-Hydroxy-epiandrosterone-mediated regulation of the prostaglandin synthesis pathway in human peripheral blood monocytes. 2008 Steroids pmid:18555503
Tang J et al. Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway. 2014 Stem Cells Dev. pmid:24730450
Urade Y and Hayaishi O Prostaglandin D2 and sleep/wake regulation. 2011 Sleep Med Rev pmid:22024172